{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T11:01:54Z","timestamp":1783162914464,"version":"3.54.6"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004951","name":"Atat\u00fcrk \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007246","name":"Y\u00fcksek\u00f6\u011fretim Kurulu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.108938","type":"journal-article","created":{"date-parts":[[2025,8,31]],"date-time":"2025-08-31T21:43:06Z","timestamp":1756676586000},"page":"108938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Synthesis of novel benzene bissulfonamides with carbonic anhydrase and choline esterase inhibitory properties"],"prefix":"10.1016","volume":"165","author":[{"given":"U\u011fur","family":"Cano\u011flu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ak\u0131n","family":"Ak\u0131nc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necla","family":"\u00d6zta\u015fk\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"\u00c7a\u011fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcya","family":"Sa\u011flamta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00fclya","family":"Ak\u0131nc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00fcleyman","family":"G\u00f6ksu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.108938_bb0005","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ejmech.2018.11.017","article-title":"Pharmaceutical and medicinal significance of sulfur (SVI)-containing motifs for drug discovery: A critical review","volume":"162","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0010","doi-asserted-by":"crossref","first-page":"4100","DOI":"10.1002\/anie.201610456","article-title":"Sulfonimidamides in medicinal and agricultural chemistry","volume":"56","author":"Chinthakindi","year":"2017","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108938_bb0015","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1021\/jm4019614","article-title":"Discovery of (E)-3-((styrylsulfonyl)methyl)pyridine and (E)-2-((styrylsulfonyl)methyl)pyridine derivatives as anticancer agents: synthesis, structure-activity relationships, and biological activities","volume":"57","author":"Lu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0020","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1016\/j.bmcl.2007.05.048","article-title":"Synthesis of benzothiazole semicarbazones as novel anticonvulsants--the role of hydrophobic domain","volume":"17","author":"Siddiqui","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108938_bb0025","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.ejmech.2017.12.064","article-title":"Discovery of novel high potent and cellular active ADC type PTP1B inhibitors with selectivity over TC-PTP via modification interacting with C site","volume":"144","author":"Du","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0030","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2174\/092986708783497247","article-title":"Nimesulide is a selective COX-2 inhibitory, atypical non-steroidal anti-inflammatory drug","volume":"15","author":"Suleyman","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0035","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2014.07.052","article-title":"Design, synthesis, antimicrobial evaluation and molecular docking studies of some new thiophene, pyrazole and pyridone derivatives bearing sulfisoxazole moiety","volume":"84","author":"Nasr","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0040","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ejmech.2015.09.001","article-title":"Novel 1,4-naphthoquinone-based sulfonamides: synthesis, QSAR, anticancer and antimalarial studies","volume":"103","author":"Pingaew","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0045","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1747-0285.2010.00956.x","article-title":"Inhibition of HIV-1 replication by isoxazolidine and isoxazole sulfonamides","volume":"75","author":"Loh","year":"2010","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108938_bb0050","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bioorg.2015.09.008","article-title":"Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer\u2019s disease: in vitro studies against yeast \u03b1-glucosidase, acetylcholinesterase and butyrylcholinesterase","volume":"63","author":"Riaz","year":"2015","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131927","article-title":"The effect of benzenesulfonamide's side chains on their human carbonic anhydrase I\/II inhibitory activities","volume":"1250","author":"Yang","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108938_bb0060","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1526-4610.2009.01437.x","article-title":"Zelrix: a novel transdermal formulation of sumatriptan","volume":"49","author":"Pierce","year":"2009","journal-title":"Headache"},{"key":"10.1016\/j.bioorg.2025.108938_bb0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/00007691-200306000-00015","article-title":"Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma","volume":"25","author":"Keil","year":"2003","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.bioorg.2025.108938_bb0070","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170685","article-title":"Glibenclamide induces apoptosis by activating reactive oxygen species dependent JNK pathway in hepatocellular carcinoma cells","volume":"37","author":"Yan","year":"2017","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bioorg.2025.108938_bb0075","unstructured":"A.M.M. Mjalli, B. Gaddam, M. Rao, M. Bondlela, R. Gopalaswamy, R.C.R.C. Andrews, S. Davis, S. Simila, T. Ren. Bissulfonamide compounds as agonists of galr1, compositions, and methods of use. WO2006047302A1. 2006. Available from: https:\/\/patents.google.com\/patent\/WO2006047302A1."},{"key":"10.1016\/j.bioorg.2025.108938_bb0080","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0223-5234(97)89847-9","article-title":"Carbonic anhydrase inhibitors: synthesis and inhibitory properties of 1,3,4-thiadiazole-2,5-bissulfonamide","volume":"31","author":"Supurant","year":"1996","journal-title":"Eur. J. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108938_bb0085","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1517\/13543776.11.11.1797","article-title":"Bissulfonamides as inhibitors of the dehydroquinate synthetase enzyme AroB and of the type II dehydroquinase enzyme AroQ","volume":"11","author":"Arrow Therapeutics Ltd.: WO0128537","year":"2001","journal-title":"Expert Opin. Ther. Patents"},{"key":"10.1016\/j.bioorg.2025.108938_bb0090","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1021\/acsmedchemlett.2c00504","article-title":"Discovery of Bis-sulfonamides as novel inhibitors of mitochondrial NADH-Quinone oxidoreductase (complex I)","volume":"24;14(2)","author":"Tsuji","year":"2023","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.108938_bb0095","volume":"22","author":"Apiraksattayakul","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108938_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.08.001","article-title":"Synthesis, molecular docking, and QSAR study of bis-sulfonamide derivatives as potential aromatase inhibitors","volume":"27","author":"Leechaisit","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bioorg.2015.11.002","article-title":"Novel biphenyl bis-sulfonamides as acetyl and butyrylcholinesterase inhibitors: synthesis, biological evaluation and molecular modeling studies","volume":"64","author":"Mutahir","year":"2016","journal-title":"Bioorg. Chem."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108938_bb0110","doi-asserted-by":"crossref","first-page":"20K","DOI":"10.1016\/0002-9149(90)91272-8","article-title":"Clinical update: spironolactone and altizide as monotherapy in systemic hypertension","volume":"65","author":"Dueymes","year":"1990","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108938_bb0115","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"10.1016\/j.bioorg.2025.108938_bb0120","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202000496","article-title":"Synthesis of novel sulfonamides with anti-Alzheimer and antioxidant capacities","volume":"354","author":"G\u00f6k","year":"2021","journal-title":"Arch. Pharm."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108938_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.202300545","article-title":"Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions","volume":"357","author":"El Ati","year":"2024","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2025.108938_bb0130","first-page":"194","article-title":"Recent advances in synthesis of sulfonamides: A review","volume":"8","author":"Das","year":"2018","journal-title":"CBI"},{"issue":"24","key":"10.1016\/j.bioorg.2025.108938_bb0135","doi-asserted-by":"crossref","first-page":"9495","DOI":"10.1021\/acs.orglett.0c03505","article-title":"Primary sulfonamide synthesis using the Sulfinylamine reagent N-Sulfinyl-O-(tert-butyl)hydroxylamine, t-BuONSO","volume":"22","author":"Davies","year":"2020","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2025.108938_bb0140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/molecules28010051","article-title":"Sulfonamides with heterocyclic periphery as antiviral agents","volume":"28","author":"Moskalik","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.108938_bb0145","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/anie.201809930","article-title":"Asymmetric stepwise reductive amination of sulfonamides, Sulfamates, and a Phosphinamide by nickel catalysis","volume":"58","author":"Zhao","year":"2019","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.bioorg.2025.108938_bb0150","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0020-1693(00)00382-0","article-title":"Metallacyclic platinum(II) bis(sulfonamides)","volume":"314","author":"Evans","year":"2001","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bioorg.2025.108938_bb0155","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S0103-50532010000300005","article-title":"Asymmetric transfer hydrogenation of ketones in aqueous solution catalyzed by rhodium(III) complexes with C2-symmetric Fluorene-ligands containing, chiral (1R,2R)-Cyclohexane-1,2-diamine","volume":"21","author":"Montalvo-Gonz\u00e1lez","year":"2010","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108938_bb0160","doi-asserted-by":"crossref","first-page":"14320","DOI":"10.1039\/C6DT02669A","article-title":"The synthesis and structures of 1,1\u2032-bis(sulfonyl)ferrocene derivatives","volume":"45","author":"Chanawanno","year":"2016","journal-title":"Dalton Trans."},{"key":"10.1016\/j.bioorg.2025.108938_bb0165","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1016\/0040-4020(92)80020-G","article-title":"A catalytic enantioselective reaction using a C2-symmetric disulfonamide as a chiral ligand: alkylation of aldehydes catalyzed by disulfonamide-Ti(O-i-Pr)4-Dialkyl zinc system","volume":"48","author":"Takahashi","year":"1992","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108938_bb0170","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1021\/ja971367f","article-title":"Chiral magnesium Bis(sulfonamide) complexes as catalysts for the merged Enolization and enantioselective amination of N-Acyloxazolidinones. A catalytic approach to the synthesis of Arylglycines","volume":"119","author":"D. A. Evans S. G. Nelson.","year":"1997","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108938_bb0175","doi-asserted-by":"crossref","first-page":"5005","DOI":"10.1021\/jo991704y","article-title":"Asymmetric cyclopropanation of allylic alcohols employing sulfonamide\/Schiff base ligands","volume":"65","author":"Balsells","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0180","first-page":"29","article-title":"Application of mono- and bis-sulfonamides in asymmetric catalysis","volume":"12","author":"Somanathan","year":"2016","journal-title":"Current Topics in Catalysis"},{"key":"10.1016\/j.bioorg.2025.108938_bb0185","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1007\/s12035-018-1388-y","article-title":"The possibility of an infectious etiology of Alzheimer disease","volume":"56","author":"Ashraf","year":"2019","journal-title":"Mol. Neurobiol."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108938_bb0190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0195","article-title":"World Alzheimer Report 2021: Journey through the diagnosis of dementia","volume":"30","author":"Gauthier","year":"2022","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.bioorg.2025.108938_bb0200","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/B978-0-12-803959-5.50003-9","article-title":"Enzyme inhibitors involved in the treatment of Alzheimer\u2019s disease","author":"Revadigar","year":"2014","journal-title":"Drug Design and Discovery in Alzheimer\u2019s Disease"},{"key":"10.1016\/j.bioorg.2025.108938_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-018-0107-y","article-title":"Alzheimer's disease hypothesis and related therapies","volume":"7","author":"Du","year":"2018","journal-title":"Transl. Neurodegene"},{"key":"10.1016\/j.bioorg.2025.108938_bb0210","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.2147\/IJN.S200490","article-title":"Alzheimer's disease: pathogenesis, diagnostics, and therapeutics","author":"Tiwari","year":"2019","journal-title":"Int. J. Nanomedicine"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108938_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41392-019-0063-8","article-title":"History and progress of hypotheses and clinical trials for Alzheimer's disease","volume":"4","author":"Liu","year":"2019","journal-title":"Sig Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108938_bb0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: targeting the cholinergic system","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0225","first-page":"1","article-title":"A review of the cholinergic system and therapeutic approaches to treat brain disorders","author":"Bertrand","year":"2020","journal-title":"Behavioral Pharmacology of the Cholinergic System"},{"issue":"7","key":"10.1016\/j.bioorg.2025.108938_bb0230","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.bioorg.2025.108938_bb0235","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.3390\/s18124281","article-title":"Cholinesterases and engineered mutants for the detection of organophosphorus pesticide residues","volume":"18","author":"Xu","year":"2018","journal-title":"Sensors"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108938_bb0240","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3390\/molecules28031035","article-title":"Galantamine based novel acetylcholinesterase enzyme inhibitors: A molecular modeling design approach","volume":"28","author":"Silva","year":"2023","journal-title":"Mol"},{"issue":"25","key":"10.1016\/j.bioorg.2025.108938_bb0245","doi-asserted-by":"crossref","DOI":"10.1002\/slct.202301158","article-title":"Synthesis and evaluation of Quinazolin-4 (3H)-one derivatives as multitarget metabolic enzyme inhibitors: A biochemistry-oriented drug design","volume":"8","author":"Tokal\u0131","year":"2023","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.bioorg.2025.108938_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107152","article-title":"A comprehensive review of multi-target directed ligands in the treatment of Alzheimer's disease","volume":"144","author":"Pathak","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0255","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bioorg.2019.02.013","article-title":"Synthesis, biological evaluation and molecular docking of novel pyrazole derivatives as potent carbonic anhydrase and acetylcholinesterase inhibitors","volume":"86","author":"Turkan","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108938_bb0260","first-page":"1479","article-title":"Cholinesterase inhibitors as Alzheimer's therapeutics","volume":"20","author":"Sharma","year":"2019","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108938_bb0265","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1039\/C9DT03897C","article-title":"Design, synthesis, characterization of peripherally tetra-pyridine-triazole-substituted phthalocyanines and their inhibitory effects on cholinesterases (AChE\/BChE) and carbonic anhydrases (hCA I, II and IX)","volume":"49","author":"Arslan","year":"2020","journal-title":"Dalton Trans."},{"issue":"6","key":"10.1016\/j.bioorg.2025.108938_bb0270","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3109\/14756366.2015.1120723","article-title":"The human carbonic anhydrase isoenzymes I and II inhibitory effects of some hydroperoxides, alcohols, and acetates","volume":"31","author":"Kose","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108938_bb0275","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1021\/jm501573b","article-title":"Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties","volume":"58","author":"Boztas","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106725","article-title":"4-Cyanamido-substituted benzenesulfonamides act as dual carbonic anhydrase and cathepsin inhibitors","volume":"139","author":"Abdoli","year":"2023","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108938_bb0285","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10426507.2024.2365702","article-title":"In silico and in vitro inhibition abilities of novel benzene sulfonamides on carbonic anhydrase and choline esterases","volume":"199","author":"Surgun","year":"2024","journal-title":"Phosphorus, Sulfur Relat. Elem"},{"key":"10.1016\/j.bioorg.2025.108938_bb0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104272","article-title":"Synthesis and biological evaluation of some coumarin hybrids as selective carbonic anhydrase IX and XII inhibitors","volume":"104","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0295","article-title":"Carbonic anhydrase inhibitors: structural insights and therapeutic potential","volume":"108224","author":"Singh","year":"2025","journal-title":"Bioorg. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108938_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3390\/metabo8020025","article-title":"Carbonic anhydrases and metabolism","volume":"8","author":"Supuran","year":"2018","journal-title":"Metabolites"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108938_bb0305","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1007\/s11030-022-10578-3","article-title":"Acetylphenyl-substituted imidazolium salts: synthesis, characterization, in silico studies and inhibitory properties against some metabolic enzymes","volume":"27","author":"Demirci","year":"2023","journal-title":"Mol. Divers."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108938_bb0310","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.2174\/1389557520666200905125738","article-title":"From antibacterial to antitumour agents: A brief review on the chemical and medicinal aspects of sulfonamides","volume":"20","author":"Azevedo-Barbosa","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0315","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1055\/s-0035-1562503","article-title":"Recent Functionalizations of primary sulfonamides","volume":"48","author":"Chen","year":"2016","journal-title":"Synthesis"},{"key":"10.1016\/j.bioorg.2025.108938_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131662","article-title":"Synthesis of sulfonamide and their synthetic and therapeutic applications: recent advances","volume":"76","author":"Mondal","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bioorg.2025.108938_bb0325","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/adsc.200505162","article-title":"Synthesis of new C2-symmetrical bissulfonamide ligands and application in the enantioselective addition of alkynylzinc to aldehydes and ketones","volume":"347","author":"Ni","year":"2005","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.bioorg.2025.108938_bb0330","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1080\/00397910802219171","article-title":"Synthesis of some new macrocyclic Bis-sulfonamides by fast addition method","volume":"38","author":"Eshghi","year":"2008","journal-title":"Synth. Commun."},{"key":"10.1016\/j.bioorg.2025.108938_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111609","article-title":"Potential therapeutic natural products against Alzheimer's disease with reference of acetylcholinesterase","volume":"139","author":"Ahmed","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioorg.2025.108938_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.132358","article-title":"Synthesis, molecular docking and some metabolic enzyme inhibition properties of biphenyl-substituted chalcone derivatives","volume":"1254","author":"Burmaoglu","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.108938_bb0345","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22952","article-title":"Synthesis and some enzyme inhibition effects of isoxazoline and pyrazoline derivatives including benzonorbornene unit","volume":"36","author":"Yavari","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116393","article-title":"Yuanzhi powder inhibits tau pathology in SAMP8 mice: mechanism research of a traditional Chinese formula against Alzheimer's disease","volume":"311","author":"Li","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.127392","article-title":"Phenyl-quinoline derivatives as lead structure of cholinesterase inhibitors with potency to reduce the GSK-3\u03b2 level targeting Alzheimer's disease","volume":"253","author":"Noori","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0360","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/biom9100592","article-title":"Butyrylcholinesterase protein ends in the pathogenesis of alzheimer's disease\u2014could BCHE genotyping be helpful in alzheimer's therapy?","volume":"9","author":"Jasiecki","year":"2019","journal-title":"Biomolecules"},{"issue":"15","key":"10.1016\/j.bioorg.2025.108938_bb0365","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms20153841","article-title":"Role of carbonic anhydrases and inhibitors in acid\u2013base physiology: insights from mathematical modeling","volume":"20","author":"Occhipinti","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.108938_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2021.772278","article-title":"Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer's disease and stroke","volume":"13","author":"Lemon","year":"2021","journal-title":"Front. Aging Neurosci."},{"issue":"21","key":"10.1016\/j.bioorg.2025.108938_bb0375","doi-asserted-by":"crossref","first-page":"19077","DOI":"10.1021\/acs.jmedchem.4c01555","article-title":"Inhibition of Pseudomonas aeruginosa carbonic anhydrases, exploring ciprofloxacin functionalization toward new antibacterial agents: an in-depth multidisciplinary study","volume":"67","author":"Marinacci","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0380","first-page":"1","article-title":"Synthesis of 4-sulfamoyl phenyl diazocarboxylic acid derivatives as novel non-classical inhibitors of human carbonic anhydrase II activity: an in vitro study","author":"Fatahian Bavandpour","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"35","key":"10.1016\/j.bioorg.2025.108938_bb0385","doi-asserted-by":"crossref","first-page":"16429","DOI":"10.1039\/D3NJ02991C","article-title":"Mechanistic insights into chloramphenicol-mediated inactivation of cytochrome P450 enzymes and their active site mutants","volume":"47","author":"Kamel","year":"2023","journal-title":"New J. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2025.108938_bb0390","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202400548","article-title":"Cyclization of acyl thiosemicarbazides led to new helicobacter pylori \u03b1-carbonic anhydrase inhibitors","volume":"357","author":"Gumus","year":"2024","journal-title":"Arch. Pharm."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108938_bb0400","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1747-0285.2007.00483.x","article-title":"New method for fast and accurate binding-site identification and analysis","volume":"69","author":"Halgren","year":"2007","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.bioorg.2025.108938_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2021.107565","article-title":"Cholinesterases, carbonic anhydrase inhibitory properties and in silico studies of novel substituted benzylamines derived from dihydrochalcones","volume":"94","author":"Ak\u0131nc\u0131o\u011flu","year":"2021","journal-title":"Comput. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bioorg.2025.108938_bb0410","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0022-2836(82)90153-X","article-title":"A geometric approach to macromolecule-ligand interactions","volume":"161","author":"Kuntz","year":"1982","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0415","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1002\/cber.18940270364","article-title":"Einfluss der configuration auf die wirkung der enzyme","volume":"27","author":"Fischer","year":"1984","journal-title":"Ber. Dtsch. Chem. Ges."},{"key":"10.1016\/j.bioorg.2025.108938_bb0420","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1073\/pnas.44.2.98","article-title":"Application of a theory of enzyme specificity to protein synthesis","volume":"44","author":"Koshland Jr.","year":"1958","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"22","key":"10.1016\/j.bioorg.2025.108938_bb0425","doi-asserted-by":"crossref","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of human acetylcholinesterase in complex with pharmacologically important ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0430","series-title":"V. Crystal structure of human carbonic anhydrase isozyme XII with 2, 3, 5, 6-Tetrafluoro-4-(propylthio) benzenesulfonamide","author":"Smirnov","year":"2018"},{"issue":"33","key":"10.1016\/j.bioorg.2025.108938_bb0435","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1039\/C5CC01854D","article-title":"X-ray crystallography-promoted drug design of carbonic anhydrase inhibitors","volume":"51","author":"Ivanova","year":"2015","journal-title":"Chem. Commun."},{"issue":"1\u20133","key":"10.1016\/j.bioorg.2025.108938_bb0440","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(96)00423-1","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings","volume":"23","author":"Lipinski","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioorg.2025.108938_bb0445","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.108938_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcab.2022.102417","article-title":"Evaluation of the in vitro antioxidant, antidiabetic and anticholinergic properties of rosmarinic acid from rosemary (Rosmarinus officinalis L.)","volume":"43","author":"Topal","year":"2022","journal-title":"Biocatal. Agric. Biotechnol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108938_bb0455","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/14756366.2012.750311","article-title":"Carbonic anhydrase inhibitory properties of novel sulfonamide derivatives of aminoindanes and aminotetralins","volume":"29","author":"Akbaba","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"1\u20132","key":"10.1016\/j.bioorg.2025.108938_bb0460","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103134","article-title":"Novel 2-aminopyridine liganded Pd (II) N-heterocyclic carbene complexes: synthesis, characterization, crystal structure and bioactivity properties","volume":"91","author":"Erdemir","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108938_bb0470","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3109\/14756366.2015.1054820","article-title":"The effects of some bromophenols on human carbonic anhydrase isoenzymes","volume":"31","author":"Taslimi","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108938_bb0475","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1021\/ja01318a036","article-title":"The determination of enzyme dissociation constants","volume":"56","author":"Lineweaver","year":"1934","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2025.108938_bb0480","series-title":"Maestro","author":"Schr\u00f6dinger","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108938_bb0485","series-title":"Protein Preparation","author":"Schr\u00f6dinger","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108938_bb0490","series-title":"SiteMap","author":"Schr\u00f6dinger","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108938_bb0495","series-title":"LigPrep","author":"Schro\u00f6dinger","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108938_bb0500","series-title":"Induced Fit Docking Protocol, Glide, Prime","author":"Schr\u00f6dinger","year":"2022"},{"key":"10.1016\/j.bioorg.2025.108938_bb0505","series-title":"QikProp","author":"Schr\u00f6dinger","year":"2022"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825008181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:30:40Z","timestamp":1762223440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825008181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":100,"alternative-id":["S0045206825008181"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108938","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of novel benzene bissulfonamides with carbonic anhydrase and choline esterase inhibitory properties","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108938"}}